Genomines
Paris, France · Founded 2021
- Headquarters
- Paris
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- genomines.com
- Last Round
- Series ASep 2025
- Rounds
- 1
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Genomines is a biotechnology and agriculture company that grows strategic metals. The company genetically enhances hyperaccumulator plants to extract battery-grade nickel from polluted soils, delivering high-grade metal at a fraction of the cost and emissions of traditional mining. Founded in 2021 by Fabien Koutchekian and Dr. Dali Rashid as part of the Entrepreneur First Paris cohort, Genomines operates labs in Paris and field operations in Johannesburg, serving battery and EV manufacturers seeking sustainable nickel supply.
Summary
Genomines is a Biotech company based in Paris, France, founded in 2021. Its most recent funding was a Series A round in Sep 2025. Investors include Engine Ventures, Forbion Capital Partners and Lowercarbon Capital.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Investors
Similar Companies
Nuclear fusion energy company building the world's first commercial fusion power plant; has a 50 ...
Solugen manufactures lower-carbon specialty chemicals using its Bioforge platform, combining enzy...
AI infrastructure company building renewable-powered data centers and cloud compute optimized for...
China's leading blood products manufacturer
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genomines"><img src="https://indexed.vc/api/badge/company/genomines" alt="Genomines on Indexed.vc" width="260" height="76" /></a>